Raymond James & Associates PORTOLA PHARMACEUTICALS INC Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 Apr 21, 2020	SELL	N/A	-38,788 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	N/A	-4,795 Reduced 11.0%	38,788 $926,000
Q3 2019 Nov 07, 2019	SELL	N/A	-6,308 Reduced 12.64%	43,583 $1.17 Million
Q2 2019 Aug 06, 2019	SELL	N/A	-26,383 Reduced 34.59%	49,891 $1.35 Million
Q1 2019 May 06, 2019	BUY	N/A	41,610 Added 120.04%	76,274 $2.65 Million
Q4 2018 Feb 11, 2019	SELL	N/A	-18,653 Reduced 34.99%	34,664 $677,000
Q3 2018 Nov 14, 2018	BUY	N/A	13,015 Added 32.29%	53,317 $1.42 Million
Q2 2018 Aug 14, 2018	BUY	N/A	20,441 Added 102.92%	40,302 $1.52 Million
Q1 2018 May 14, 2018	BUY	N/A	11,961 Added 151.41%	19,861 $649,000
Q4 2017 Feb 14, 2018	BUY	N/A	3,330 Added 72.87%	7,900 $385,000
Q3 2017 Nov 13, 2017	BUY	N/A	4,570	4,570 $247,000

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.